by Jenna Ogilvie | Dec 16, 2019 | Commentary, Perspectives
Reflecting on my Patient Experience Doctors told me I had a large tumor attached to a nerve in my spinal cord. The tumor was precariously expanding into my chest cavity, and there was a likelihood of paralysis if I did not act. Surgery was my only option. I am...
by Jenna Ogilvie | Dec 2, 2019 | Commentary, Perspectives
One of the most neglected social determinants of health is access to adequate transportation. While housing, education, social inequality (as reflected by the Gini coefficient), and income are widely recognized as important factors of well-being, it is striking...
by Jenna Ogilvie | Nov 18, 2019 | Commentary, Perspectives
Customers searching for consumer goods (e.g., home appliances, electronics) can make use of an abundance of information about the quality of available options (e.g., through Consumer Reports, Consumersearch.com). In contrast, consumers seeking a health care...
by Jenna Ogilvie | Oct 28, 2019 | Commentary, Perspectives
Introduction One-third of the US population has health literacy levels that are basic or below basic [1]. This statistic, while surprising, is not unique to the United States: limited health literacy impacts access to appropriate health-related services around...
by Jenna Ogilvie | Oct 28, 2019 | Discussion Paper, Perspectives
Foreword The Global Future Council on Neurotechnologies represents a diverse group of experts drawn from psychiatry, psychology, brain science, technology, advocacy and the public sector. They are passionate about stimulating the global conversation on mental...
by Jenna Ogilvie | Oct 21, 2019 | Commentary, Perspectives
Introduction Health care systems are operating in an environment that is increasingly moving toward value-based payments that reward good health outcomes and patient experience. An impediment to success in this environment, however, is that both health care...
by Jenna Ogilvie | Sep 30, 2019 | Discussion Paper, Perspectives
Introduction Cell-, gene-, and tissue-based advanced therapeutic products, referred to in this paper as “cell and gene therapy” (CGT) products, have the potential to address many unmet medical needs. These products are commonly discovered and developed in...
by Jenna Ogilvie | Sep 23, 2019 | Commentary, Perspectives
Every day in clinical practice, health care clinicians make difficult decisions about appropriate treatment and care for their patients. Years of training prepare them for this responsibility, to choose the best course of action for a patient based on their...
by Jenna Ogilvie | Sep 9, 2019 | Commentary, Perspectives
Those working on changing the course of the opioid crisis cannot afford to overlook simple solutions that could bring timely, positive results. Changing the policies that impact buprenorphine prescribing could have immediate impacts on access to...
by Jenna Ogilvie | Aug 30, 2019 | Discussion Paper, Perspectives
ABSTRACT | Predicting and preparing for the unforeseen is challenging. Medicine and health care are continuously changing based on science, technology, and regulation. This very process of change creates pathways for surprise and leaves us vulnerable to...
